Jun 09, 2023 / 04:15PM GMT
Owen McMenamy - Jefferies Group (Trades, Portfolio) LLC - Analyst
(audio in progress) My name is [Owen McMenamy]. I'd like to introduce Cue Biopharma, and Daniel Passeri, CEO.
Daniel Passeri - Cue Biopharma, Inc. - CEO
Yeah, thank you very much. Welcome, everyone. Appreciate your interest and listening in.
Just as a reminder, Cue Biopharma is a Nasdaq-listed company with the symbol, CUE.
Before we begin, I'd like to just thank Jefferies for giving us an opportunity to present. Presentation may contain some forward-looking statements.
Okay. I'll start off with overall company's vision, is we focus on protein engineering, basically translating nature's cues into protein therapeutics for immune modulation. And when we say nature's cues, that's where
Cue Biopharma Inc at Jefferies Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers